|
|
|
| Webinar: Viral Vector for Rare and Ultra-rare Disease | Rare and ultra-rare disease programs require viral vector strategies tailored to smaller patient populations. Explore practical approaches to right-size development and manufacturing, determine appropriate scale, reduce costs and timelines, and align processes with clinical and commercial needs. This webinar will share practical strategies for leveraging manufacturing partners and advancing toward proof of concept and clinical validation efficiently and cost-effectively. Click here to learn more. |
|
|
FOCUS ON TRANSLATIONAL RESEARCH |
|
|
|
By Cell & Gene: The Podcast | In episode 137 of Cell & Gene: The Podcast, Host Erin Harris talks with Sylke Poehling, Ph.D., SVP and Global Head: Therapeutic Modalities, pRED; Roche Gene Therapy Center of Excellence about how the company selects the optimal modality by starting with disease biology. | |
|
|
|
| Manufacturing of "MSC 2.0" Using Functionally Closed Systems | Application Note | By Ho Yoon Khei, Jun Yung Woo, and Khang Luu, Corning Life Sciences | Transitioning to closed systems enables the 100-fold expansion of engineered cells. Achieve high yields and maintain anti-cancer potency while reducing contamination risks and labor. |
|
|
| Past, Present And Future Of Digital PCR | E-Book | Bio-Rad Laboratories, Inc. | Move beyond relative quantification to achieve absolute precision. Learn how partitioning technology overcomes traditional limitations to deliver reproducible gene expression data for rare targets. |
|
|
|
| Robust Database Characterizes And Optimizes Product Development | White Paper | By Karin Marek, Maximilian Fuchs, Dr. Elke Sternberger-Rützel, Harro Höfliger | Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance. |
|
|
|
|
|
|
TRANSLATIONAL RESEARCH SOLUTIONS |
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
